DOJ Raids Perrigo In Generic Drug Price-Fixing Probe

Law360, Fort Wayne (May 3, 2017, 1:20 PM EDT) -- Generic-drug maker Perrigo Co. PLC said late Tuesday that the U.S. Department of Justice has carried out search warrants at its corporate offices, making the company the latest to be swept up in the agency’s ongoing probe of pricing in the industry.

Perrigo did not say what drugs were the target of the DOJ’s investigation, but the generic manufacturer has been accused of colluding with other pharmaceutical companies to artificially inflate prices for topical skin creams.

“As has been previously disclosed by a number of companies, the antitrust division has been looking at industrywide pricing practices,” Perrigo said in the statement....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS